Fundz
Following Pacific Hybreed, Inc.?

Get the free weekly funding digest

The latest funding rounds, like Pacific Hybreed, Inc.’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New funding rounds, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Industry Trends

See who's moving and how much in your market

No credit card required Weekly funding digest

Pacific Hybreed raised $1M in a funding round, backed by Hawaiʻi Angels and Blue Startups. The funds will be used to scale hatchery production and expand breeding programs.

PRIVATEMay 05, 2026about 2 months ago

Amount Raised

$1 Million

Round Type

seed

Bainbridge IslandInformation Technology

Investors

Blue StartupsHawaiʻi Angels

Description

Pacific Hybreed, a Kailua-Kona and Honolulu, HI-based aquaculture biotechnology company, raised $1M in funding. Backers included Hawaiʻi Angels and Blue Startups. The company intends to use the funds to scale hatchery production, expand its farm-specific breeding programs, and continue broadening into additional species beyond Pacific oysters, including clams. Led by CEO Melissa DellaTorre, Pacific Hybreed is developing high-performance oyster and clam seed through hybrid breeding techniques.

Company Information

Company

Pacific Hybreed, Inc.

Location

10610 NE MANITOU PARK BLVD.

Bainbridge Island, Washington, United States

About

On a global scale, shellfish aquaculture provides a sustainable, low input source of healthy food. When practiced sustainably, shellfish farming can enhance water quality while providing habitat and other ecosystem services in the marine environment. Pacific Hybreed is the first commercial shellfish breeding company in the U.S. Our products offer both resilience, to mitigate the impact of threats to current production, and growth, through enhanced yield for producing Pacific oysters, Manila clams, Kumamoto oysters, and rock scallops, among other commercially important shellfish. Based on decades of university-based research by founders Dennis Hedgecock and Joth Davis, our technology responds to a changing global climate, warmer and more acidic oceans, and emerging diseases, including Pacific Oyster Mortality Syndrome (POMS), a viral disease that has devastated oyster production worldwide. Specifically, hybrid vigor, resulting from our crossbreeding program based on world class quantitative genomics, can enhance yield and resilience in shellfish, as it has in corn and other crops, without relying on genes from unrelated species (i.e., no GMOs). Our products will not interbreed with wild stocks.

Related People

Suggested for you
1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Pacific Hybreed, Inc.'s next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Pacific Hybreed, Inc.? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan